Southland Equity Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Sell
4,656
-329
-7% -$29.4K 0.08% 173
2026
Q1
$358K Sell
4,985
-145
-3% -$11.2K 0.07% 187
2025
Q4
$407K Sell
5,130
-85
-2% -$6.7K 0.08% 169
2025
Q3
$393K Buy
5,215
+100
+2% +$6.85K 0.08% 160
2025
Q2
$353K Buy
5,115
+98
+2% +$6.43K 0.08% 164
2025
Q1
$340K Buy
5,017
+32
+0.6% +$1.92K 0.08% 164
2024
Q4
$224K Buy
4,985
+1,523
+44% +$85.4K 0.05% 205
2024
Q3
$218K Buy
+3,462
New +$202K 0.05% 210

Other funds holding CVS

Southland Equity Partners's CVS Position: Q2 2026 in Review

Southland Equity Partners reduced its CVS Health (CVS) stake by 6.6% in Q2 2026, selling an estimated $29.4K and leaving 4,656 shares worth $482K. The position accounts for 0.08% of the portfolio, ranked #173.

Southland Equity Partners first reported a position in CVS in Q3 2024 and has held it in 8 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Southland Equity Partners held 4,656 shares of CVS Health worth $482K as of Q2 2026.
  • Southland Equity Partners sold 329 CVS Health shares in Q2 2026, an estimated $29.4K.
  • CVS Health made up 0.08% of Southland Equity Partners's portfolio in Q2 2026, its #173 holding.
  • Southland Equity Partners first reported a position in CVS Health in Q3 2024 and has held it in 8 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.